Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes: A Report From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial
- 29 April 2008
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 51 (17) , 1645-1652
- https://doi.org/10.1016/j.jacc.2007.11.081
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- Predictors and 1-year outcome of major bleeding in patients with non–ST-elevation acute coronary syndromes: Insights from the Canadian Acute Coronary Syndrome RegistriesAmerican Heart Journal, 2005
- Impact of In-Hospital Acquired Thrombocytopenia in Patients Undergoing Primary Angioplasty for Acute Myocardial InfarctionThe American Journal of Cardiology, 2005
- Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes MellitusJournal of the American College of Cardiology, 2005
- Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary SyndromesJAMA, 2004
- Heparin and Low-Molecular-Weight HeparinChest, 2004
- Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromesPublished by Oxford University Press (OUP) ,2004
- Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)European Heart Journal, 2003
- Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary SyndromesCirculation, 2001
- Abciximab reduces mortality in diabetics following percutaneous coronary interventionJournal of the American College of Cardiology, 2000